Stock Market Aarti Drugs stock in focus as Q2 FY25 results show 6.3% revenue decline to ₹543.09… Aditya Bhagchandani Oct 25, 2024
Corporates Aarti Drugs Q2 FY25 Results: Revenue declines 6.3% YoY to Rs 543 crore, Profit… Markets Desk Oct 24, 2024
Stock Market Aarti Drugs shares surge over 2% after arm gets GMP certificate from UK MHRA Aman Shukla Oct 4, 2024
Corporates Aarti Drugs’ subsidiary Pinnacle Life Science receives GMP certificate from… Aditya Bhagchandani Oct 4, 2024
Stock Market Aarti Drugs Buyback Opens Today, Set to Close on 18th September 2024 News Desk Sep 11, 2024
Stock Market Aarti Drugs shares surge 10% ahead of board meeting on sixth buyback plan Aditya Bhagchandani Aug 22, 2024
